Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, March 20, 2019
Merck KGaA, Darmstadt, Germany and Pfizer announced the discontinuation of the ongoing Phase III JAVELIN Ovarian PARP 100 study evaluating avelumab in combination with chemotherapy.
read more
Merck KGaA, Darmstadt, Germany, a leading science and technology company which operates its biopharmaceutical business in the US and Canada as EMD Serono, has entered into a collaboration and licensing agreement with Domain Therapeutics, Strasbourg, ...
read more
Friday, February 28, 2020
Merck KGaA, Darmstadt, Germany and AMCM, Starnberg, Germany, announced a cooperation agreement on the 3D printing of tablets.
read more
Wednesday, September 21, 2022
Accumulus Synergy, a non-profit organization working to develop an information and data exchange platform aimed at transforming how life science innovators and health authorities worldwide interact, announced that Merck, known as MSD outside the ...
read more
Merck announced an investment of €150 million in its manufacturing site at Aubonne, Switzerland, to expand manufacturing capacity for its biotech medicines.
read more
Wednesday, September 21, 2022
Merck will initiate a new Phase 3 clinical program with once-daily islatravir for the treatment of people with HIV-1 infection.
read more
Wednesday, November 18, 2015
Merck KGaA, Darmstadt, Germany, has announced the completion of its $17 billion acquisition of Sigma-Aldrich.
read more
Merck announced the successful completion of the cash tender offer, through a subsidiary, for all of the outstanding shares of common stock of ArQule at a purchase price of $20.00 per share.
read more
Thursday, November 19, 2015
Merck and Pfizer today have announced that the US Food and Drug Administration (FDA) has granted avelumab, an investigational fully human anti-PD-L1 IgG1 monoclonal antibody, Breakthrough Therapy designation for the treatment of patients with ...
read more
Wednesday, March 13, 2013
Merck, known as MSD outside the United States and Canada, and Luminex Corporation have signed a collaboration and license agreement to develop a companion diagnostic device that will be evaluated to help screen patients for recruitment into Merck's ...
read more
Friday, December 21, 2012
Merck, known as MSD outside the United States and Canada, and GE Healthcare today announced a clinical study collaboration, license and supply agreement for use of [18F]Flutemetamol, an investigational positron emission tomography (PET) imaging agent...
read more
Wednesday, November 11, 2020
MercachemSyncom has acquired Admescope based in Oulu, Finland and Södertälje, Sweden.
read more
A. Menarini and Orion Corporation have signed a multi-year licensing agreement for Menarini Asia-Pacific to distribute and commercialize several of Orion’s Easyhaler products in 10 countries in Asia-Pacific region.
read more
The Menarini Group and Radius Health announced the companies have entered into an exclusive global license agreement for development and commercialization of elacestrant.
read more
Wednesday, March 21, 2018
MellingMedical was recently awarded a Federal Supply Schedule 65IB Drugs, Pharmaceuticals and Hematology Related Products.
read more